Immutep Ltd Files 6-K Report
Ticker: PRRUF · Form: 6-K · Filed: Jun 28, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Jun 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, corporate-update
TL;DR
Immutep (IMPP) filed a 6-K, standard corporate update. Nothing major, just keeping the SEC updated.
AI Summary
Immutep Limited filed a Form 6-K on June 28, 2024, reporting information as of June 27, 2024. The company, previously known as Prima BioMed Ltd, is incorporated in Australia and its fiscal year ends on June 30. Its principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Why It Matters
This filing provides routine updates on Immutep's corporate status and reporting requirements as a foreign private issuer, which is important for investors tracking the company's compliance and basic information.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- IMMUTEP Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- June 27, 2024 (date) — Date of report
- June 28, 2024 (date) — Filing date
- Level 32, Australia Square 264 George Street, Sydney NSW 2000, Australia (location) — Principal executive office address
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide routine updates to the SEC.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on June 28, 2024.
What is Immutep Limited's former company name?
Immutep Limited's former company name was Prima BioMed Ltd.
Where is Immutep Limited's principal executive office located?
Immutep Limited's principal executive office is located at Level 32, Australia Square 264 George Street, Sydney NSW 2000, Australia.
Does Immutep Limited file annual reports under Form 20-F or Form 40-F?
Immutep Limited files annual reports under Form 20-F.
Filing Stats: 263 words · 1 min read · ~1 pages · Grade level 16.9 · Accepted 2024-06-28 06:32:57
Filing Documents
- d798849d6k.htm (6-K) — 9KB
- d798849dex991.htm (EX-99.1) — 28KB
- g798849g23o94.jpg (GRAPHIC) — 15KB
- 0001193125-24-171192.txt ( ) — 59KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: June 27, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer